The 4th BioInnovation Summit to be held on April 1-2 2023

Dear Speakers, Invited Guests, Exhibitors and Sponsors,

The 4th BioInnovation Summit postponed last December will be held on April 1-2 2023 at Hangzhou International Exhibition Center. We will continue to make the conference  another unprecedented event for industrial cooperation and communication. We hereby express our sincere thanks for your understanding and support after its postponement. 


See you in Hangzhou!


The Committee of  BioInnovation Summit

January 5th 2023


Speakers
Guo-Liang Yu
Chairman and CEO of Apollomics
Yingfei Wei
Chairperson of BioInnovation Summit, Chairwoman of BioInnovation Institute.
Bruce Beutler

Director of Center for the Genetics of Host Defense, UT Southwestern, 2011 Nobel Laureate in Physiology or Medicine


George Hara

George Hara, Group Chairman and CEO of DEFTA Partners, Chairman of the Board of Alliance Forum Foundation in Special Consultative Status with the UN Economic and Social Council

Lin Xu
Chairman and Partner of China-U.S. Green Fund
Weili Hong

Visiting Professor at School of Economics of Fudan University

Tianjin Xu
Professor at School of Archaeology and Museology of Peking University, Director of Liangzhu Museum (Liangzhu Institute) 
Kejian Huang

Founder of SinoType, Chairman and General Manager of Beijing SinoType Technology, Chief Multimedia Planner of Beijing Olympic Bid Committee Presentation Report

Yingxian Xiao
Dean of BioInnovation Institute
Yi-Wei Tang

Chief Medical Officer of Danaher Corporation/Cepheid China, Fellow of American Academy of Microbiology

Yao-Wei Huang
Professor in Department of Veterinary Medicine of Zhejiang University
Shibo Jiang
Director of Institute of Medical Microbiology in Fudan University, Fellow of American Academy of Microbiology
Jianwei Wang

Vice President of Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS/PUMC)

Ning Li
CEO of Shanghai Junshi Biosciences 
Shoubai Chao
COO of CanSinoBIO
Peizhuo Zhang
Chairman of Suzhou GenePharma
Yuling Li

Co-founder and CEO of Innoforce Pharmaceuticals

Jin Liang
Managing Director of CICC
Dong Shen
Founder and CEO of RNAimmune 
Long-Cheng Li

Founder, Chairman and CEO of Ractigen Therapeutics

Jia Fei
Professor/Doctoral Supervisor of School of Basic Medicine in Jinan University, Director of Guangdong Engineering Research Center for Small RNA Drug Development
Yu Wu
Partner & Patent Attorney of JunHe
Yun Yang
CTO of Shanghai Circode Biomed  
Yongsheng Yang
Senior VP of Zhejiang Haichang Biomedical Technology Co., Ltd. and Director of Nucleic Acid Medicine Innovation Center (NAMIC)
Frank Xiaofeng Qin
 Co-founder and Chief Scientific Officer of Fantasia Biopharma
Zihui Fang
Head of Center for Excellence of Innoforce Pharmaceuticals 
Bob Zhang
CEO and Co-founder of Epigenic Therapeutics 
Yuwen Liu
Founding Partner of BOHE Angel Fund
Lu Gao
CEO of Therorna Inc.
Dajie Tang

Chairman of Triwise Capital 

Guoping Zhao
Member of Chinese Academy of Sciences
Daniel Ramon Vidal
Member of Royal Academy of Engineering of Spain
Jian-Dong Huang
Chair Professor at School of Biomedical Sciences, University of Hong Kong.
Shenlin Wang

Professor at Institute of Biotechnology in East China University of Science and Technology

Enwei Xie

Partner of Transfar Innovation Polis Fund

Xibin Zhou
Co-founder, Chairman and General Manager of Synceres Biosciences
Baishan Fang

Professor at Xiamen University, Founder of Xiamen City Key Laboratory of Synthetic Biotechnology

Yiming Li

Professor at Southern University of Science and Technology, Co-founder and Chief Scientific Officer of Shengrui Biotech


Zale Cao

CEO of JIMI Biotechnology Co., Ltd.


Ran Chao
Co-founder and CEO of LifeFoundry
Ben Zhao

 Founder and President of Zhejiang Haichang Biotech Co., Ltd.


Gang Chen

CSO of R&G PharmaStudies

Juhong Liu

CEO of GlobalSubmissions Consulting

Hongliu Ding

VP of Pulmongene

Shen Xiao
Chief Strategy Officer of 3D Medicines
Yaning Wang

CEO of Createrna Science and Technology

Shichun Zhang
BD Director of Novotech Shanghai
Tom Du

Chairman of the Board of Evergreen Therapeutics

Ruyi He
Chief Medical Officer of RemeGen, Chief Scientist of SDIC Fund Management CO., LTD
Jinjie Hu
President and CEO of Axteria Biomedical Consulting and ClearDx Labs
Sharon Liang
General Manager (US) and Vice President of Global Regulatory and Quality Affairs , Burning Rock Dx
Grace Zhou
CEO and Chairman of ImmVira 
Hongliang Zong

Vice President of CMC in Neukio Biotherapeutics

Claire Zhang

 CTO and Co-founder of Innostellar Biotherapeutics 

Lin Yang

CEO and Founder of PersonGen

Jingmin Zhou
CEO and Co-founder of Genemagic Biosciences
Tina Liu
Senior Associate of AllBright Law Offices
Al Lin

CEO of Innoland Biosciences (USA/China)

Fred Mao
Partner and Managing Director of Frost & Sullivan 
Min Zhu
Senior VP of CDMO Operations of Innoforce Pharmaceuticals
Mark Ma

VP Operation of Lab-Direct

Guang Gao
Senior Technical Officer at PATH China Office, Former FDA Senior Reviewer
Weihua Song
VP of Innoland Biosciences
Jinsong Guo
Founder of DrugTimes, Co-Chairman and Secretary General of China Alliance for New Drug Development for Liver Diseases.
Long Zhang
Co-founder and President of MindRank AI in China
Fengfeng Xu
Executive Vice President of Abogenbio
Kelvin Shao
Vice General Manager of Kexing Biopharm Co., Ltd. 
William Haseltine

professor
Professor, Central Academy of Fine Arts

professor
Professor, Central Academy of Fine Arts

Agenda
  • Keynote Program
  • Session A
  • Session B
  • Session C
Keynote Program
April 1st 2023, Saturday
Hangzhou International Expo Center
Time
Speech
Speaker
08:30 - 09:00
Opening Ceremony
Reserve
Keynote Program
09:00 - 09:40
Immortality, the Ultimate Challenge of Life Science
Bruce Beutler
Reserve
09:40 - 10:20
Long-term Perspective - Create a Society Where Every Person Can Live a Healthy Life Until His/Her Last Moment
George Hara
Reserve
10:20 - 10:30
Stay Younger, Happier and Healthier: Announcing Dr. Guo-Liang Yu's 2nd Book
Guo-Liang Yu
Reserve
10:30 - 10:45
Coffee Break
Reserve
10:45 - 11:25
What Are New Drivers of Economic Growth in China?
Lin Xu
Reserve
11:25 - 12:00
The New Frontier of PE/VC Market in China with a Global Perspective
Weili Hong
Reserve
12:20 - 13:20
Lunch Program: Information Design of Chinese Ideograph in the Context of Meta Universe
Kejian Huang
Reserve
A Long and Complicated Relationship of Humans and Viruses: Past, Present and Future.
14:00 - 14:30
The Past and the Present of Clinical Virology
Yi-Wei Tang
Reserve
14:30 - 15:00
The Current and Future of COVID-19 Vaccines
Shibo Jiang
Reserve
15:00 - 15:30
Emerging Animal Coronaviruses: Interspecies Transmission and Control
Yao-Wei Huang
Reserve
15:30 - 15:45
Coffee Break
Reserve
15:45 - 16:00
Inauguration of Xiaoshan Female Entrepreneurs Alliance in Biopharma Industry Chain
Reserve
16:00 - 16:30
Virus Mutation and Responses: Challenges and Prospects
Jianwei Wang
Reserve
16:30 - 17:00
Progress in Antiviral Vaccines
Shoubai Chao
Reserve
17:00
Closing
Reserve
17:00 - 19:00
Light Dinner
Reserve
19:00 - 20:30
BioInnovation Talent Show
Reserve
Session A
April 2nd 2023, Sunday
Hangzhou International Expo Center
Time
Speech
Speaker
RNA Era: Its Technologies, Products, Pain Points, and Future.
09:00 - 09:10
Opening Remarks
Reserve
11:20 - 12:00
Small RNA-based Drugs Development and Manufacturing: Opportunities and Challenges
Peizhuo Zhang
Reserve
09:50 - 10:30
Touching the Void – Delivering Oligonucleotides to the CNS
Long-Cheng Li
Reserve
10:30 - 10:45
Coffee Break
Reserve
10:45 - 11:20
Introduction of a New Track for Developing Small Nucleic Acid Drugs Targeting miRNA in Non-coding RNA
Jia Fei
Reserve
09:10 - 09:50
mRNA Technologies: Opportunities and Challenges
Dong Shen
Reserve
12:20 - 13:20
Lunch Program: Archaeology, a Window to Know the World
Tianjin Xu
Reserve
14:00 - 14:05
Opening Remarks
Yuling Li
Reserve
14:05 - 14:30
Patent Landscape Surrounding LNP and Recent Cases
Yu Wu
Reserve
14:30 - 14:55
Develop Technology Platform for Circular RNA Therapies
Yun Yang
Reserve
14:55 - 15:20
QTsomes for Delivery of Nucleic Acid Therapeutics
Yongsheng Yang
Reserve
15:20 - 15:45
Application of Recombinant RNA Virus Vectors in Vaccine Development and Vaccine Immune Evaluation
Xiaofeng Qin
Reserve
15:45 - 16:00
Coffee Break
Reserve
16:00 - 16:25
The End-to-End CMC Development Strategies and Challenges for mRNA Vaccines/Drugs
Zihui Fang
Reserve
16:25 - 16:50
Novel Therapies Development for Chronic Diseases Based on Endogenous Epigenetic Regulation Mechanism
Bob Zhang
Reserve
16:50 - 17:30
Panel Discussion: Innovation in mRNA era - Dialogue with Investors
Yuling Li, Jin Liang, Dong Shen, Peizhuo Zhang, Yu...
Reserve
17:30
Closing of Session A
Reserve
Session B
April 2nd 2023, Sunday
Hangzhou International Expo Center
Time
Speech
Speaker
Biosynthesis
09:00 - 09:05
Opening Remarks
Dajie Tang
Reserve
09:05 - 09:30
Biosynthesis and Biotechnology: from Creation for Use to Industrial Transformation
Guoping Zhao
Reserve
09:30 - 10:00
Postbiotics: Microbiome Modulators for the Future
Daniel Ramon Vidal
Reserve
10:00 - 10:30
Program Bacteria to Treat Cancer
Jian-Dong Huang
Reserve
10:30 - 10:45
Coffee Break
Reserve
10:45 - 11:05
From Discovery to Intelligent Manufacturing of Microbial Drugs
Shenlin Wang
Reserve
11:05 - 12:00
Panel Discussion: The New Frontier of Synthetic Biology
Enwei Xie, Xibin Zhou, Baishan Fang, Yiming Li, Za...
Reserve
12:20 - 13:20
Lunch Program: Archaeology, a Window to Know the World
Tianjin Xu
Reserve
Winning at the Starting Line for Chinese Pharmaceutical Companies' Oversea Strategy - in light of the FDA New Policy
14:00 - 14:05
Opening Remarks
Ben Zhao
Reserve
14:05 - 14:30
Key Considerations for the Global Clinical Trial(MRCT) Design and Case Studies
Gang Chen
Reserve
14:30 - 14:55
Management of CMC Changes from Clinical to Commercial-Transition from Quality to Quantity
Juhong Liu
Reserve
14:55 - 15:20
Discussion on the Clinical Trial Strategy of Domestic Innovative Pharmaceutical Companies Applying for Drug Registration both in China and the United States
Hongliu Ding
Reserve
15:20 - 15:45
Drug Development Strategies based on New Clinical Value Guidelines
Shen Xiao
Reserve
15:45 - 16:00
Coffee Break
Reserve
16:00 - 16:25
The Impact of FDA Optimus and Equity Projects on Global Oncology New Drug Development
Yaning Wang
Reserve
16:25 - 16:50
Simultaneous Global Development of China-originated Innovative Drugs
Shichun Zhang
Reserve
16:50 - 17:30
Panel Discussion: The Dawn of Chinese Innovative Biopharma Going Global
Tom Du, Ruyi He, Ning Li, Gang Chen, Shen Xiao, Y...
Reserve
17:30
Closing of Session B
Reserve
Session C
April 2nd 2023, Sunday
Hangzhou International Expo Center
Time
Speech
Speaker
Cell Gene Therapy: How to Do Better
09:00 - 09:05
Opening Remarks
Grace Zhou
Reserve
09:05 - 09:30
Driving Next Generation Cell Therapy with iPSC-CAR-NK
Hongliang Zong
Reserve
09:30 - 10:00
AAV-based Gene Therapies: CMC Development and IND Filing
Claire Zhang
Reserve
10:00 - 10:30
The Latest Progress and Trend of Global CAR-T Cell Therapy for Solid Tumor
Lin Yang
Reserve
10:30 - 10:45
Coffee Break
Reserve
10:45 - 11:10
The Challenge and Breakthrough of Oncolytic Virus
Grace Zhou
Reserve
11:10 - 11:35
Novel AAV Capsid Engineering Platform and its Application in Neurological Diseases
Jingmin Zhou
Reserve
11:35 - 12:00
Cell and Gene Therapy Regulation and Pre-IPO Compliance Strategies in China and the United States
Tina Liu
Reserve
12:20 - 13:20
Lunch Program: Archaeology, a Window to Know the World
Tianjin Xu
Reserve
CXO (CRO, CDMO, CPO): “Silk Road Stations" for Innovative Drug R&D
14:00 - 14:15
Paradigm Shift in Biopharma Industry and the Prospect of CXOs: Building“Silk Road Stations" for Innovative Drug R&D
Al Lin
Reserve
14:15 - 14:45
Overview of CXO Business in China
Fred Mao
Reserve
14:45 - 15:05
Be a Proud CDMO that Enables New Drug Development
Min Zhu
Reserve
15:05 - 15:25
CPO (Contract Procurement Organization): SPM Supply Chain Builds a Highway" for Biomedical Industry
Mark Ma
Reserve
15:25 - 15:45
Global Regulation Road Map on ATMP Products Regulatory CMC- A Road Map for a Successful Journey
Guang Gao
Reserve
15:45 - 16:00
Coffee Break
Reserve
16:00 - 16:20
CRO Cooperation Mode of AI-enabling Biotech under New Global Competition
Long Zhang
Reserve
16:20 - 16:40
Role of NHPs in Biopharma Research
Weihua Song
Reserve
16:40 - 17:30
Panel Discussion: Your Dream CXO Partner - a Sponsors’Perspective
Jinsong Guo, Al Lin, Long Zhang, Fengfeng Xu, Kelv...
Reserve
17:30
Closing of Session C
Reserve
Live Stream
Keynote
Session A
Session B
Session C
Tel:0571-82816999 Website:www.bioinnovation-summit.com Mailbox:bioinnovationsummit@vip.163.com

Copyright © 2019-2023 BioInnovation Summit All Rights Reserved 浙公网安备33010902003140号 浙ICP备20024304号-1. Designed by Wanhu.